Education
About Us
Working with TipRanks
Follow Us
Astrazeneca Plc (AZN)
NASDAQ:AZN
AZN Analyst Ratings
Strong Buy
6 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AZN Stock 12 Month Forecast
Average Price Target
$118.77
▲(79.17% Upside)
| Highest Price Target$200.39 | Average Price Target$118.77 | Lowest Price Target$88.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Goldman Sachs
Reiterated
04/09/25
Bank of America Securities
Reiterated
04/02/25
Berenberg Bank
Reiterated
03/26/25
TD Cowen
Reiterated
03/19/25
Leerink Partners
Reiterated
02/26/25
Erste Group
―
Hold
―
Downgraded
09/30/24
AstraZeneca downgraded to Hold from Buy at Erste GroupAstraZeneca downgraded to Hold from Buy at Erste Group
Unknown Analyst
Not Ranked
BOCOM International Holdings Company
$93.3
Buy
40.75%
Upside
Initiated
07/18/24
BOCOM Intl starts AstraZeneca (AZN) at BuyBOCOM Intl initiates coverage on AstraZeneca (NASDAQ: AZN) with a Buy rating and a price target of $93.30.
Jefferies
$74
Hold
11.63%
Upside
Reiterated
07/02/24
AstraZeneca (AZN) Gets a Hold from Jefferies
Argus Research
$80→$85
Buy
28.22%
Upside
Reiterated
05/30/24
AstraZeneca price target raised to $85 from $80 at ArgusAstraZeneca price target raised to $85 from $80 at Argus
Morgan Stanley
$85→$84
Buy
26.72%
Upside
Reiterated
04/22/24
AstraZeneca (AZN) PT Lowered to $84 at Morgan StanleyMorgan Stanley analyst Mark Purcell lowered the price target on AstraZeneca (NASDAQ: AZN) to $84.00 (from $85.00) while maintaining a Overweight rating.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Goldman Sachs
Reiterated
04/09/25
Bank of America Securities
Reiterated
04/02/25
Berenberg Bank
Reiterated
03/26/25
TD Cowen
Reiterated
03/19/25
Leerink Partners
Reiterated
02/26/25
Erste Group
―
Hold
―
Downgraded
09/30/24
AstraZeneca downgraded to Hold from Buy at Erste GroupAstraZeneca downgraded to Hold from Buy at Erste Group
Unknown Analyst
Not Ranked
BOCOM International Holdings Company
$93.3
Buy
40.75%
Upside
Initiated
07/18/24
BOCOM Intl starts AstraZeneca (AZN) at BuyBOCOM Intl initiates coverage on AstraZeneca (NASDAQ: AZN) with a Buy rating and a price target of $93.30.
Jefferies
$74
Hold
11.63%
Upside
Reiterated
07/02/24
AstraZeneca (AZN) Gets a Hold from Jefferies
Argus Research
$80→$85
Buy
28.22%
Upside
Reiterated
05/30/24
AstraZeneca price target raised to $85 from $80 at ArgusAstraZeneca price target raised to $85 from $80 at Argus
Morgan Stanley
$85→$84
Buy
26.72%
Upside
Reiterated
04/22/24
AstraZeneca (AZN) PT Lowered to $84 at Morgan StanleyMorgan Stanley analyst Mark Purcell lowered the price target on AstraZeneca (NASDAQ: AZN) to $84.00 (from $85.00) while maintaining a Overweight rating.
Best Analysts Covering AstraZeneca
Which Analyst Should I Follow If I Want to Buy AZN and Sell After:
1 Month
xxx
Success Rate
22/33 ratings generated profit
Average Return
+2.47%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +2.47% per trade.
3 Months
xxx
Success Rate
13/22 ratings generated profit
Average Return
+2.81%
reiterated a xxx
rating 26 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 59.09% of your transactions generating a profit, with an average return of +2.81% per trade.
1 Year
Success Rate
18/25 ratings generated profit
Average Return
+9.86%
reiterated a buy rating 12 days ago
Copying Sachin Jain's trades and holding each position for 1 Year would result in 72.00% of your transactions generating a profit, with an average return of +9.86% per trade.
2 Years
xxx
Success Rate
20/25 ratings generated profit
Average Return
+19.36%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +19.36% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AZN Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
0
0
0
0
1
Buy
13
17
15
17
14
Hold
0
0
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
17
15
18
16
Each month's total comprises the sum of three months' worth of ratings.
AZN Financial Forecast
AZN Stock Forecast FAQ
What is AZN’s average 12-month price target, according to analysts?
Based on analyst ratings, Astrazeneca Plc’s 12-month average price target is $118.77.
What is AZN’s upside potential, based on the analysts’ average price target?
Astrazeneca Plc has 79.17% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AZN a Buy, Sell or Hold?
Astrazeneca Plc has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
What is Astrazeneca Plc’s price target?
The average price target for Astrazeneca Plc is $118.77. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $200.39 ,the lowest forecast is $88.00. The average price target represents 79.17% Increase from the current price of $66.29.
The highest analyst price target is $200.39 ,the lowest forecast is $88.00. The average price target represents 79.17% Increase from the current price of $66.29.
What do analysts say about Astrazeneca Plc?
Astrazeneca Plc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of AZN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.